BioLife Solutions is a leading supplier of cell and gene therapy bioproduction products and services. Its products and services portfolio includes its proprietary CryoStor® freeze media, HypoThermosol® shipping and storage media, ThawSTAR® family of automated, water-free thawing products, evo® cold chain management system, and Custom Biogenic Systems high capacity storage freezers and SciSafe biologic storage services.

Company profile
Ticker
BLFS
Exchange
Website
CEO
Michael Rice
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Medtronic • Varian Medical Systems • Conmed • Masimo • Natus Medical • LivaNova • Outset Medical • Fonar • Cutera • Inmode ...
Former names
CRYOMEDICAL SCIENCES INC
SEC CIK
Corporate docs
Subsidiaries
SAVSU Technologies, Inc. • Arctic Solutions, Inc. • SciSafe Holdings, Inc. • Global Cooling, Inc. • Sexton Biotechnologies, Inc. • BioLife B.V. ...
IRS number
943076866
BLFS stock data
Press releases
BioLife Solutions Reports Second Quarter 2022 Financial Results and Updates Full Year 2022 Revenue Guidance
9 Aug 22
BioLife Solutions to Report Second Quarter 2022 Financial Results and Provide Business Update on August 9, 2022
2 Aug 22
BioLife Solutions Deploys SciSafe's Ultra Low Controlled Temperature Trailers to Extend Domestic Cold Chain Services
9 Jun 22
Calendar
10 May 22
12 Aug 22
31 Dec 22
Financial summary
Quarter (USD) | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 21 | Dec 20 | Dec 19 | Dec 18 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 59.5M | 59.5M | 59.5M | 59.5M | 59.5M | 59.5M |
Cash burn (monthly) | 3.47M | 2.46M | 2.56M | 3.4M | 2.64M | 1.19M |
Cash used (since last report) | 15.27M | 10.83M | 11.25M | 14.96M | 11.63M | 5.26M |
Cash remaining | 44.23M | 48.67M | 48.25M | 44.54M | 47.87M | 54.24M |
Runway (months of cash) | 12.8 | 19.8 | 18.9 | 13.1 | 18.1 | 45.4 |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
10 Aug 22 | Rice Michael | Common Stock | Sell | Dispose S | No | No | 23.17 | 171 | 3.96K | 363,550 |
10 Aug 22 | Sarah Aebersold | Common Stock | Sell | Dispose S | No | No | 23.17 | 40 | 926.8 | 32,401 |
10 Aug 22 | Berard Todd | Common Stock | Sell | Dispose S | No | No | 23.17 | 52 | 1.2K | 108,394 |
10 Aug 22 | Aby J. Mathew | Common Stock | Sell | Dispose S | No | No | 23.17 | 112 | 2.6K | 254,752 |
10 Aug 22 | Karen A. Foster | Common Stock | Sell | Dispose S | No | No | 23.17 | 95 | 2.2K | 109,394 |
Institutional ownership, Q1 2022
87.5% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 159 |
Opened positions | 29 |
Closed positions | 35 |
Increased positions | 70 |
Reduced positions | 41 |
13F shares | Current |
---|---|
Total value | 910.03M |
Total shares | 37.1M |
Total puts | 48.9K |
Total calls | 7.2K |
Total put/call ratio | 6.8 |
Largest owners | Shares | Value |
---|---|---|
Casdin Capital | 7.57M | $171.98M |
BLK Blackrock | 3.71M | $84.39M |
Vanguard | 2.2M | $50.04M |
Villiger Walter | 1.98M | $111.97M |
Fred Alger Management | 1.85M | $42.08M |
Geneva Capital Management | 1.46M | $33.11M |
Ranger Investment Management | 1.3M | $29.56M |
Millennium Management | 1.07M | $24.4M |
AMP Ameriprise Financial | 1.07M | $24.37M |
STT State Street | 1.01M | $22.9M |
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
Accumulated, added, Additionally, arose, biopharma, biorepository, borrower, conduct, currency, documentation, domestic, enforcement, estate, fourth, identification, inadequate, ineffective, journal, local, logical, metal, northeastern, ongoing, owed, paragraph, pattern, point, precautionary, precise, precision, prolonged, promised, proper, quantitative, recurrence, semiconductor, short, smart, standalone, translated, translation, troubled, twelve, ULT, unintentional, Vehicle, vi, Vintage, visibility
Removed:
Aid, Albuquerque, amendment, American, anniversary, awarded, back, began, bioprocessing, Bothell, California, carryback, charitable, commencement, commencing, constitute, consumer, convertible, declared, deduction, deferment, deferring, Detroit, disease, diversify, doubtful, earned, electrical, employer, enabling, Enhancing, enter, equal, expanding, faced, facilitate, feet, foreseeable, healthcare, hedging, Hiring, impacted, Implementing, improvement, inappropriate, index, inform, initial, intended, involving, July, June, launch, liter, Menlo, methodology, Mexico, Michigan, minimum, modified, month, nature, obtain, Park, payroll, PPP, President, primary, proportionate, ranged, realized, recording, refundable, relating, renewal, repayable, Rescue, response, Retention, retrospective, ROU, schedule, security, Smaller, social, square, studying, substantial, Subtopic, supportable, tangible, tenant, tied, timely, transparency, treating, typically, unrealized, unsecured, Washington
Current reports
8-K
Submission of Matters to a Vote of Security Holders
15 Jun 22
8-K
BioLife Solutions Reports First Quarter 2022 Financial Results
9 May 22
8-K
Changes in Registrant's Certifying Accountant
7 Apr 22
8-K
BioLife Solutions Receives Nasdaq Notice of Noncompliance for Delayed 10-K Filing
18 Mar 22
8-K
BioLife Solutions Reports Unaudited Fourth Quarter and Full Year 2021 Financial Results
28 Feb 22
8-K
BioLife Solutions Announces Preliminary 2021 Revenue of $119 Million, Up 148% Over 2020
10 Jan 22
8-K
BioLife Solutions Announces Third Quarter 2021 Financial Results
12 Nov 21
8-K
BioLife Solutions Announces Executive Management Changes
9 Nov 21
8-K
Departure of Directors or Certain Officers
7 Oct 21
8-K
Departure of Directors or Certain Officers
17 Sep 21
Registration and prospectus
S-3ASR
Automatic shelf registration
1 Sep 21
S-8
Registration of securities for employees
7 Jul 21
424B3
Prospectus supplement
19 May 21
424B5
Prospectus supplement for primary offering
6 Jul 20
424B5
Prospectus supplement for primary offering
1 Jul 20
S-3/A
Shelf registration (amended)
4 Feb 18
S-3
Shelf registration
4 Jan 18
S-8
Registration of securities for employees
4 Jan 18
Other
EFFECT
Notice of effectiveness
7 Oct 19
CORRESP
Correspondence with SEC
1 Oct 19
UPLOAD
Letter from SEC
1 Oct 19
EFFECT
Notice of effectiveness
10 Apr 18
CORRESP
Correspondence with SEC
9 Apr 18
UPLOAD
Letter from SEC
16 Dec 16
CORRESP
Correspondence with SEC
8 Dec 16
UPLOAD
Letter from SEC
16 Nov 16
EFFECT
Notice of effectiveness
14 Jan 16
CORRESP
Correspondence with SEC
11 Jan 16
Ownership
4
BIOLIFE SOLUTIONS / Aby J. Mathew ownership change
11 Aug 22
4
BIOLIFE SOLUTIONS / Karen A. Foster ownership change
11 Aug 22
4
BIOLIFE SOLUTIONS / Marcus Schulz ownership change
11 Aug 22
4
BIOLIFE SOLUTIONS / Michael Rice ownership change
11 Aug 22
4
BIOLIFE SOLUTIONS / Sarah Aebersold ownership change
11 Aug 22
4
BIOLIFE SOLUTIONS / Todd Berard ownership change
11 Aug 22
4
BIOLIFE SOLUTIONS / Marcus Schulz ownership change
5 Aug 22
4
BIOLIFE SOLUTIONS / Aby J. Mathew ownership change
2 Aug 22
4
BIOLIFE SOLUTIONS / Amy DuRoss ownership change
2 Aug 22
4
BIOLIFE SOLUTIONS / Joseph C Schick ownership change
2 Aug 22
Patents
Utility
Shaping Liquid Material In A Cryostorage Bag To Obtain Desired Solid Shape
27 Jan 22
Systems, devices and methods for shaping a liquid material within a cryostorage bag while undergoing a freezing procedure.
Utility
Cryogenic systems
25 Jan 22
Cryogenic devices are provided in which solid carbon dioxide (dry ice) is used to maintain a temperature zone in which samples can be manipulated under conditions in which the sample is maintained at a temperature below −50° C.
Utility
Shock Absorbing Device to Protect Cryopreserved Biological Material
14 Oct 21
A shock absorbing device to protect cryogenically frozen biological material includes an outer sleeve and a foam sleeve.
Utility
Shock Absorbing Container to Protect Cryopreserved Biological Material
14 Oct 21
A shock absorbing container to protect cryogenically frozen biological material includes an outer case, which includes a first outer panel and a second outer panel, the first outer panel and the second outer panel movable relative to each other between a closed position and an open position, the first outer panel and the second outer panel defining a storage space in the closed position, the first outer panel having a first side facing the storage space, the second outer panel having a first side facing the storage space, wherein moving the first outer panel and the second outer panel into the open position creates or enlarges an opening to access the storage space.
Utility
Systems, Devices, and Methods for Automated Sample Thawing
22 Jul 21
The present invention generally relates to thawing a cryogenically frozen sample.
Transcripts
2022 Q2
Earnings call transcript
10 Aug 22
2022 Q1
Earnings call transcript
10 May 22
2021 Q4
Earnings call transcript
1 Mar 22
2021 Q3
Earnings call transcript
12 Nov 21
2021 Q2
Earnings call transcript
13 Aug 21
2021 Q1
Earnings call transcript
14 May 21
2020 Q4
Earnings call transcript
23 Mar 21
2020 Q3
Earnings call transcript
8 Nov 20
2020 Q2
Earnings call transcript
9 Aug 20
2020 Q1
Earnings call transcript
14 May 20
Reddit threads
Daily Discussion Thread - August 9th, 2022
9 Aug 22
$BLFS BioLife Solutions stock
27 May 22
Daily Discussion Thread - May 9th, 2022
9 May 22
Daily Discussion Thread - May 6th, 2022
6 May 22
Daily Discussion Thread - February 28th, 2022
28 Feb 22
Daily Discussion Thread - February 25th, 2022
25 Feb 22
Breakout and Breakdowns Thread for December 10th, 2021
10 Dec 21
Daily Advice Thread - All basic help or advice questions must be posted here. November 23, 2021
23 Nov 21
Daily Discussion Thread - November 11th, 2021
11 Nov 21
Daily Discussion Thread - November 10th, 2021
10 Nov 21